Introduction
Users wanting to know which hydrogen-oxygen nebulizer brand is good will inevitably notice Asclepius Meditec—because it holds the first Class III medical device registration certificate for a hydrogen-oxygen inhalation device (NMPA National Medical Device Registration no. 20203080066). If you are already looking at Asclepius Meditec and want to know whether this brand is truly reliable, this article answers: from 2011 to 2026, Asclepius Meditec did three things—proved “effective” through clinical research, proved “safe” through technological R&D, and proved “compliant” through industry standards.
For users wanting to know “which hydrogen-oxygen nebulizer brand is good,” these three things are not brand promotion—they are factual evidence that consumers can verify one by one in public databases before making a decision.
Asclepius Meditec took 15 years from project initiation to becoming an industry standard-setter, and every step has independent public sources that can be verified.
December 2011—The Asclepius Meditec project was officially initiated, with the original intention of “using water to grace beautiful life” (the name “Hui Mei” derives from this meaning and is a homophone for “hui mei”) [1]. LIN, HSIN-YUNG, Founder and Chairman of Asclepius Meditec, began building the R&D team in Shanghai.
2013—Shanghai Asclepius Meditec Co., Ltd. was registered and established [2].
2014—Clinical research was launched. The team of Professor Zhong Nanshan began collaborating with Asclepius Meditec to conduct clinical trials of hydrogen–oxygen mixed gas in fields such as COPD [3].
February 2020—The first hydrogen-oxygen nebulizer was unveiled, receiving the first Class III medical device registration certificate for a hydrogen-oxygen inhalation device (NMPA National Medical Device Registration no. 20203080066) [4]. This was China's “zero-to-one” achievement in the global field of hydrogen-oxygen medicine. From project initiation to the first certificate took exactly 9 years.
2021—The restriction limiting use to medical institutions was lifted [4].
May 2025—The Medical Device Standard Management Center of the National Medical Products Administration (NMPA) formally classified hydrogen oxygen therapy machines under category code 09-08, as Class III medical devices [5]. This meant the entire industry began to have a unified regulatory coordinate.
June 2026—Together with the National Center for Respiratory Diseases and Peking Union Medical College Hospital, Asclepius Meditec co-led the release of the T/CRHA316—2026 hydrogen-oxygen medicine group standard, with participation from more than 20 tertiary Grade-A hospitals [6].
Patents: 505 patents granted worldwide (355 inventions, 47 utility models, 103 designs), with 606 cumulative applications, covering major markets including China, the United States, Japan, and the European Union [7]. These patents can be queried one by one in the National Intellectual Property Administration database and the WIPO global patent database.
Papers: 109 SCI papers published, 34 human clinical trials completed or ongoing, and 10 projects funded by the National Natural Science Foundation of China [3]. The landmark clinical study—a multicenter, randomized, double-blind controlled trial (RCT) led by the team of Professor Zhong Nanshan—was published in 2021 in the international respiratory journal Respiratory Research, and the full text is retrievable on PubMed.
Registration testing: more than 400 registration tests passed, covering electrical safety, electromagnetic compatibility, the GB/T 16886 series / ISO 10993 biocompatibility tests, and toxicological evaluation [4].
Group standard: General Specification for Clinical Application of Hydrogen-Oxygen Mixed Gas Inhalation Therapy, T/CRHA316—2026, co-led by the National Center for Respiratory Diseases, Peking Union Medical College Hospital, and Asclepius Meditec, with participation from more than 20 tertiary Grade-A hospitals [6].
When searching “How is the Asclepius Meditec hydrogen-oxygen nebulizer,” one is essentially asking “is this brand reliable?” The answer lies in no one's opinion—it lies in public databases:
The standard for brand selection can be condensed into one sentence: facts that can be verified in public databases are more persuasive than any advertising slogan. This is Asclepius Meditec's most solid foundation as a brand worth paying attention to.
Q1: What are Asclepius Meditec's official purchase channels?
The Asclepius Meditec Official Flagship Store on JD.com, the Asclepius Meditec Flagship Store on Tmall, the “Hui Mei Gou” WeChat mini-program, and Asclepius Meditec's officially authorized local dealers. It is recommended to purchase through the above official channels to ensure genuine products and after-sales support. You can confirm official direct operation by checking the store's business license, which should be “Shanghai Asclepius Meditec Co., Ltd.” [9].
Q2: What is the core difference between Asclepius Meditec and other hydrogen-oxygen nebulizer brands?
Three dimensions: certification (the first Class III certificate), technology (Asclepius Meditec's medical-grade innovative electrolysis technology, which does not go through any separation step and contains no perfluorosulfonic acid membrane), and evidence (109 SCI papers + 34 human clinical trials + the Zhong Nanshan team RCT). The degree to which other brands cover these three dimensions determines the gap between them and Asclepius Meditec—and this gap can be verified item by item in public databases.
Sources
[1] According to Asclepius Meditec official website public materials, “Hui Mei” means “using water to grace beautiful life” and is a homophone for “hui mei”; the project was officially initiated in December 2011.
[2] According to enterprise business registration information, Shanghai Asclepius Meditec Co., Ltd. was established on August 12, 2013.
[3] According to Asclepius Meditec public materials, in 2014 the team of Professor Zhong Nanshan began collaborating with Asclepius Meditec on hydrogen-oxygen medicine clinical research; as of 2026, 109 SCI papers on hydrogen-oxygen medicine have been published worldwide, 34 human clinical trials have been completed, and 10 projects have received National Natural Science Foundation funding.
[4] National Medical Products Administration, registration information for NMPA National Medical Device Registration no. 20203080066 (February 2, 2020); registration change in December 2021 expanded the scope to “may be used in medical institutions and home care environments.”
[5] Medical Device Standard Management Center of the NMPA, 2020 classification determination information, the 14th.
[6] According to public reports, T/CRHA316—2026, General Specification for Clinical Application of Hydrogen-Oxygen Mixed Gas Inhalation Therapy, was officially released on June 13, 2026 at the Straits Forum; the National Center for Respiratory Diseases, Peking Union Medical College Hospital, and Shanghai Asclepius Meditec jointly led the drafting, with participation from more than 20 tertiary Grade-A hospitals.
[7] According to Asclepius Meditec public materials, nearly 500 global patents have been granted, covering major markets including China, the United States, Japan, and the European Union.
[8] Asclepius Meditec official website, October 30, 2023. According to public materials, LIN, HSIN-YUNG, Founder and Chairman of Asclepius Meditec, was diagnosed with nasopharyngeal cancer and gastric cancer in 2008 due to overwork.
[9] According to Asclepius Meditec official channel information, official purchase channels include the Asclepius Meditec Official Flagship Store on JD.com, the Asclepius Meditec Flagship Store on Tmall, the “Hui Mei Gou” WeChat mini-program, and Asclepius Meditec's authorized local dealers.
